Tebotelimab Human Monoclonal Antibody
Tebotelimabis a research-grade recombinant antibody targeting CD223. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3, Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
UniProt
Q15116, P18627
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
[V-kappa’-VH-h-CH2-CH3_V-kappa-VH’]2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alexa Fluor™ 488-Labeled Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Tetramer Protein (MALS verified)
Tumor Necrosis Factor, Recombinant, Human (TNF, TNF-alpha, TNFA, TNF-a, Cachectin, DIF, Tumor Necrosis Factor Ligand Superfamily Member 2, TNFSF2) discontinued